NCT Number: NCT00188435
Comparison of CXR and MnDCT
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in the acutely ill patient. The hypothesis is that MnDCT is more sensitive than CXR in the detection of acute findings in the acutely ill patient.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
About this study
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in a cohort of 100 patients admitted for acute respiratory distress. Chest radiography (CXR) is compared to Minimum Dose CT (MnDCT) for the detection of consolidation;lung nodules, heart failure.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All patients admitted for investigation of acute pulmonary embolus
Exclusion criteria
- none
Treatment and study plan
Primary outcomes
-
A comparison of CXr and MnDCT in the detection of acute findings within the thorax
Sponsors and collaborators
Lead sponsor
University Health Network, Toronto
Other
Registry information
Official study title
A Comparison of Chest Radiography and Minimum Dose Chest CT
Important dates
- Study start
- 2003
- Study completion
- 2004
- First posted
- Sep 16, 2005
- Registry last updated
- Apr 24, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A New Way of Looking at Your Lungs
NCT01949402
Acute Dyspnoea, Respiration Disorders
Oxford, United Kingdom
View Trial Details